Stryker Neuro Cranial — Net Sales increased by 3.4% to $1.27B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 44.4%, from $882.00M to $1.27B. Over 3 years (FY 2021 to FY 2024), Neuro Cranial — Net Sales shows an upward trend with a 20.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong adoption of neurosurgical technologies and successful market expansion, while a decrease may signal increased competition or a slowdown in elective neuro-cranial procedures.
This metric represents the total revenue generated from the sale of neurosurgical and cranial products, including specia...
Peers in the medical technology space report similar segment-specific revenue for neuro-interventional and cranial surgery divisions, often benchmarked against overall market growth rates for neuro-surgical procedures.
syk_segment_neuro_cranial_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $620.00M | $598.00M | $648.00M | $646.00M | $674.00M | $664.00M | $768.00M | $710.00M | $746.00M | $768.00M | $874.00M | $760.00M | $832.00M | $882.00M | $1.80B | $1.13B | $1.23B | $1.27B |
| QoQ Change | — | -3.5% | +8.4% | -0.3% | +4.3% | -1.5% | +15.7% | -7.6% | +5.1% | +2.9% | +13.8% | -13.0% | +9.5% | +6.0% | +103.9% | -37.4% | +9.4% | +3.4% |
| YoY Change | — | — | — | — | +8.7% | +11.0% | +18.5% | +9.9% | +10.7% | +15.7% | +13.8% | +7.0% | +11.5% | +14.8% | +105.7% | +48.2% | +48.1% | +44.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.